×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
This workshop will be conducted in Japanese Language only.
View the Program in Japanese
Program Committee
-
Kentaro Kogushi, PhD Head of Clinical Development Neurology-Psychiatry, Japan Development
AbbVie GK, Japan -
Toshihiko Aranishi, PhD Research Scientist, Health Outcomes/Health Technology Assessment
Eli Lilly Japan K.K, Japan -
Mariko Hirozane, PhD Associate director, Policy intelligence department, Integrated Market Access Div
Janssen Pharmaceutical K.K. , Japan -
Shinya Ohno, PhD, MPH Director, HTA Strategy Professional
Chugai Pharmaceutical Co., Ltd, Japan -
Akihito Uda, MPH Health Economics & Outcome Reserch, Value & Access Division
Novartis Pharma K.K., Japan -
Hisashi Urushihara, DrPH Professor, Faculty of Pharmacy, Department of Pharmacy
Keio University, Japan -
Kentaro Yamato, RPh Head of HEOR/RWE, Medical Affairs
Otsuka Pharmaceutical Co., Ltd., Japan -
Keisuke Yoshihara, PhD, MSc HEOR Research Associate
Bayer Yakuhin, Ltd., Japan -
Manami Yoshida, DVM Associate Director, Medical Affairs – HIV & COVID-19
Gilead Sciences K.K., Japan -
Shinzo Hiroi, PhD, MPH, RPh, PMP Senior Director, Project Management, IDC ICO Real World Solutions
ICON Clinical Research GK, Japan -
Yuta Kasai Japan-Asia Clinical Development 2
Astellas Pharma Inc., Japan -
Akiko Nishioka Clinical Project Manager
Novartis Pharma K.K., Japan
Have an account?